Curis is a drug development company leveraging its innovative signaling pathway drug technologies to seek opportunities to create new targeted small molecule drug candidates for cancer. In its efforts to develop proprietary targeted cancer programs, Curis builds upon its previous experiences in targeting signaling pathways, including in the Hedgehog pathway. For more information visit the company’s Web site at www.curis.com
ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com
Let us hear your thoughts below: